FDA Warns Siemens On Marketing Claims For Syngo Arterial Health Package
This article was originally published in The Gray Sheet
Executive Summary
FDA's recent warning letter to Siemens Medical is an example of the agency's recent crackdown on unapproved marketing and promotional claims by device manufacturers